BAXTER INTERNATIONAL

baxter-international-logo

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates through three segments: BioScience, Medication Delivery, and Renal. - The BioScience segment manufactures recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsi... n deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technologies used in adult stem-cell therapies; and vaccines. - The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs, intravenous nutrition products; infusion pumps; and inhalation anesthetics. This segment also offers products and services related to pharmacy compounding, drug formulation, and packaging technologies. - The Renal segment provides products to treat end-stage renal disease and irreversible kidney failure. This segment also offers solutions and other products for peritoneal dialysis, a home-based therapy and product for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. has collaborations with HHD LLC, DEKA Products Limited Partnership, and DEKA Research and Development Corp. for the development of a home hemodialysis machine. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is headquartered in Deerfield, Illinois.

#SimilarOrganizations #People #Financial #Event #Website #More

BAXTER INTERNATIONAL

Social Links:

Industry:
Biotechnology Clinical Trials Medical

Founded:
1931-10-19

Address:
Deerfield, Illinois, United States

Country:
United States

Website Url:
http://www.baxter.com

Total Employee:
10001+

Status:
Active

Email Addresses:
Paulgregory0000@gmail.com

Total Funding:
1.68 B USD

Technology used in webpage:
Google Font API LetsEncrypt WordPress Font Awesome Domain Not Resolving Wordpress Plugins Mobile Non Scaleable Content Nginx JsDelivr Cloudflare JS


Similar Organizations

anika-therapeutics-logo

Anika Therapeutics

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its

bind-therapeutics-logo

BIND Therapeutics

BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.

biocom-logo

BIOCOM

Biocom is one of the largest regional life science association in the world

cbiz-logo

CBIZ

CBIZ, Inc., through its subsidiaries, provides professional business services primarily to small and medium-sized businesses, individuals,

ceapro-logo

Ceapro

Ceapro is into developing functionally active ingredients derived from oats and renewable plant resources for healthcare and cosmetic needs.

international-flavors-fragrances-logo

International Flavors & Fragrances

International Flavors & Fragrances Inc. is a innovator of sensorial experiences that move the world.

lorillard-logo

Lorillard

Lorillard, Inc., through its Lorillard Tobacco Company subsidiary, is the third largest manufacturer of cigarettes in the United States.

merck-research-laboratories-logo

Merck Research Laboratories

Merk Research Laboratories provide research and development in the field of healthcare.

oleander-medical-technologies-logo

Oleander Medical Technologies

Oleander Medical Technologies is developing a revolutionary new treatment to destroy many of the most invasive.

tarsa-therapeutics-logo

Tarsa Therapeutics

Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.


Current Advisors List

thomas-stallkamp_image

Thomas Stallkamp Lead Director @ Baxter International
Board_member
2014-05-01

michael-mahoney_image

Michael Mahoney Chairman @ Baxter International
Board_member
2015-10-01

patricia-morrison_image

Patricia Morrison Director @ Baxter International
Board_member
2019-02-01

carole-shapazian_image

Carole Shapazian Member of Board of Directors @ Baxter International
Board_member
2003-01-01

peter-hellman_image

Peter Hellman Member of Board of Directors @ Baxter International
Board_member
2005-01-01

jose-almeida_image

Jose Almeida Chairman @ Baxter International
Board_member

thomas-chen_image

Thomas Chen Member of Board of Directors @ Baxter International
Board_member
2012-01-01

john-forsyth_image

John Forsyth Director @ Baxter International
Board_member

Current Employees Featured

giuseppe-accogli_image

Giuseppe Accogli
Giuseppe Accogli SVP & President Global Businesses @ Baxter International
SVP & President Global Businesses
2017-04-01

stacey-eisen_image

Stacey Eisen
Stacey Eisen Vice President, Global Communications & President @ Baxter International
Vice President, Global Communications & President
2016-07-01

james-k-saccaro_image

James K. Saccaro
James K. Saccaro Corporate Vice President and Chief Financial Officer @ Baxter International
Corporate Vice President and Chief Financial Officer

david-roman_image

David Roman
David Roman Vice President, Strategy & FP&A @ Baxter International
Vice President, Strategy & FP&A
2019-09-01

david-ferguson_image

David Ferguson
David Ferguson General Manager, Medication Delivery Global Business Unit @ Baxter International
General Manager, Medication Delivery Global Business Unit
2015-10-01

sean-martin_image

Sean Martin
Sean Martin SVP & General Counsel @ Baxter International
SVP & General Counsel

matt-banet_image

Matt Banet
Matt Banet Senior Director of Research and Development @ Baxter International
Senior Director of Research and Development
2020-03-01

ellen-mcintosh_image

​Ellen McIntosh
​Ellen McIntosh SVP, Associate General Counsel @ Baxter International
SVP, Associate General Counsel
2016-05-01

john-parker_image

John Parker
John Parker CIO, Baxter Healthcare @ Baxter International
CIO, Baxter Healthcare

robert-pepper_image

Robert Pepper
Robert Pepper U.S. Commercial Marketing and Digital Health @ Baxter International
U.S. Commercial Marketing and Digital Health
2020-04-01

Founder


thomas-stallkamp_image

Thomas Stallkamp

Stock Details


Company's stock symbol is NYSE:BAX

Acquisitions List

Date Company Article Price
2021-09-02 Hill-Rom Hill-Rom acquired by Baxter International 10.5 B USD
2019-12-02 Seprafilm Seprafilm acquired by Baxter International 350 M USD
2019-09-10 Cheetah Medical Cheetah Medical acquired by Baxter International 230 M USD
2016-12-16 Claris Injectables Claris Injectables acquired by Baxter International 625 M USD
2015-03-05 SuppreMol SuppreMol acquired by Baxter International 200 M EUR
2014-07-09 AesRx AesRx acquired by Baxter International N/A
2014-04-02 Chatham Therapeutics Chatham Therapeutics acquired by Baxter International 70 M USD
2013-09-11 FLOWSENSE FLOWSENSE acquired by Baxter International N/A
2013-09-06 Gambro Gambro acquired by Baxter International N/A
2012-02-14 Synovis Life Technologies Synovis Life Technologies acquired by Baxter International N/A

Investors List

german-federal-ministry-of-education-and-research-bmbf_image

German Federal Ministry of Education and Research (BMBF)

German Federal Ministry of Education and Research (BMBF) investment in Grant - Baxter International

Investments List

Date Company Article Money raised
2022-03-15 NovaXS Biotech Baxter International investment in Seed Round - NovaXS Biotech 846.5 K USD
2022-01-10 Medically Home Baxter International investment in Venture Round - Medically Home 110 M USD
2021-11-21 Walela Baxter International investment in Seed Round - Walela 237.5 K USD
2020-05-01 Ayogo Health Baxter International investment in Series B - Ayogo Health 7.5 M USD
2014-05-06 Naurex Baxter International investment in Series C - Naurex 25 M USD
2014-01-31 Xenetic Biosciences Baxter International investment in Post-IPO Equity - Xenetic Biosciences 10 M USD
2013-10-02 Opsona Baxter International investment in Series C - Opsona 3 M EUR
2013-06-10 Ocular Therapeutix Baxter International investment in Series D - Ocular Therapeutix 23.8 M USD
2013-04-29 Opsona Baxter International investment in Series C - Opsona 33 M EUR
2013-01-29 Zytoprotec Baxter International investment in Series A - Zytoprotec 2 M EUR

Newest Events participated

ceres-conference-2018_event_image Participated in Ceres Conference 2018 on 2018-04-24 as sponsor

american-association-of-nurse-anesthetists-aana-2017-annual-congress_event_image Participated in American Association of Nurse Anesthetists (AANA) 2017 Annual Congress on 2017-09-08 as exhibitor

Official Site Inspections

http://www.baxter.com Semrush global rank: 168.98 K Semrush visits lastest month: 485.48 K

  • Host name: 104.19.161.95
  • IP address: 104.19.161.95
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Baxter International"

At the Intersection of Saving and Sustaining Lives | Baxter

Feb 3, 2025 COVID-19 (Coronavirus) Update. Updated March 24, 2020 – The coronavirus outbreak is challenging communities, relief organizations and healthcare systems throughout …See details»

Our Leadership - Baxter

Our forward-looking leadership team is made up of dedicated, focused and experienced executives. Working with each other and with our employees worldwide, their knowledge and …See details»

Our Story - Baxter

Diversity, equity and inclusion at Baxter is about building and developing diverse, high-performing teams that are engaged and innovative. We want to attract, motivate and retain an inclusive …See details»

Baxter International - Wikipedia

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. [2]The company primarily focuses on products to treat chronic and acute …See details»

Baxter - The Org

Baxter International Inc. is a Fortune 500, American health care company that primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and …See details»

Baxter - Baxter publishes annual corporate responsibility report ...

Jul 10, 2024 Provides updates on Baxter’s 2030 Corporate Responsibility Commitment and Goals and reinforces the company’s commitment to transparent reporting Baxter International …See details»

About Us | Our Story | Employer Awards and Recognition at Baxter

It all started in 1931 in Iowa when Dr. Ralph Falk and Dr. Donald Baxter launched the Don Baxter Intravenous Products Company. Hillrom’s roots go back to when Bill Hillenbrand revolutionized …See details»

Our Governance - Baxter

May 7, 2024 Baxter’s Code of Conduct is a guide for employees and suppliers, available in multiple languages, to help explain the universal principles governing our business. ...See details»

Baxter - Baxter Launches New 2030 Corporate Responsibility …

Jul 8, 2021 The company’s 2020 Corporate Responsibility Report unveils new 10-year commitment and details continued efforts to create lasting stakeholder value Baxter …See details»

Our Story - Baxter

Inclusion and diversity at Baxter is about building and developing diverse, high-performing teams that are engaged and innovative. We want to attract, motivate and retain an inclusive and …See details»

Corporate Responsibility - Baxter

Baxter will make best efforts to respond within two (2) weeks if a complaint is received regarding the manner in which it provides goods and services to people with disabilities. However, in …See details»

Life at Baxter | Baxter Careers - Baxter International

Baxter Site in Bengaluru, India The Bengaluru site at Baxter is a cutting-edge research and development facility in India, dedicated to advancing medical technology and improving patient …See details»

At the Intersection of Saving and Sustaining Lives | Baxter

Mar 24, 2020 COVID-19 (Coronavirus) Update. Updated March 24, 2020 – The coronavirus outbreak is challenging communities, relief organizations and healthcare systems throughout …See details»

Charitable Giving & Grants - Baxter

The Baxter International Foundation helps advance the company’s mission to save and sustain lives. We partner with organizations around the world to increase access to healthcare for the …See details»

Pharmaceuticals at Baxter: Manufacturing

Baxter has increased the supply of critical products, demonstrating our speed and commitment to responding to market and supply dynamics. Baxter Partnerships Baxter continually reviews …See details»

Corporate Responsibility - Baxter

Baxter and the Baxter International Foundation have invested more than $143 million since 2021 to support underserved communities through strategic partnerships and product donations. …See details»

this is where we belong - jobs.baxter.com

The Alliance for Baxter Women, or ABW, is one of our many employee-led Business Resource Groups with a purpose to share, support and build high-performing teams throughout the …See details»

Healthcare Professionals - Baxter

Chronic kidney disease (CKD) is an ongoing journey. While every journey is unique, Baxter is with you every step of the way, providing options to meet your lifestyle needs. Surgical Care We …See details»

Baxter Projects 6% Sales Growth Following Strategic Divestitures

4 days ago Baxter International has undergone a dramatic transformation over the past two years, shedding major business units to create a more focused medical technology company. …See details»

Our Products & Services - Baxter

Our global product portfolio enables healthcare professionals to be more efficient and effective in treating patients at the hospital bedside, in the operating room, in critical care units, at home …See details»

linkstock.net © 2022. All rights reserved